We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Fluidigm

Fluidigm Corporation focuses on the most pressing needs in translational and clinical research, including cancer, imm... read more Featured Products: More products

Download Mobile App




Molecular Methods Differentiate E. coli Outbreaks

By LabMedica International staff writers
Posted on 09 Dec 2015
The public health importance of Shiga toxin-producing Escherichia coli (STEC) infections, epidemiological and molecular surveillance systems are essential for early outbreak detection and in recent years, rapid advancements in the use of molecular typing methods have improved STEC surveillance and outbreak detection.

The application of these tools helps to identify disease clusters, refine outbreak case definitions, facilitate case finding, and link human cases to environmental sources. In order to achieve these outcomes, molecular typing assays must possess the discriminatory power required to distinguish between related and nonrelated bacterial isolates, have high reproducibility, and be easy to perform.

A team of scientists led by those at the Alberta Provincial Laboratory for Public Health (Calgary, AB, Canada) assessed the capacity of either high-throughput polymerase chain reaction (PCR) of 49 virulence genes, core-genome single nt variants (SNVs) or k-mer clustering to discriminate between outbreak-associated and sporadic E. coli O157:H7 isolates. Three outbreaks and multiple sporadic isolates from the province of Alberta (Canada) were included in the study. Two of the outbreaks occurred concurrently in 2014 and one occurred in 2012.

The BioMark real-time PCR system (Fluidigm; South San Francisco, CA, USA) was used for real-time PCR amplification of 49 genetic markers using 48.48 dynamic arrays. Amplifications were performed using the dyes, 6-carboxyfluorescein (FAM)- and 6-carboxy-2’, 4, 4’, 5’, 7, 7’-hexachlorofluorescein succinimidyl ester (HEX)-labelled TaqMan probes. All amplification assays included both positive and negative controls. Detection of Stx genes, stx1 and stx2 was determined using a real-time multiplex PCR assay consisting of two separate reactions run on the ABI Prism 7500FAST Sequence Detection System (Life Technologies, Inc.; Burlington, ON, Canada).

Pulsed-field gel electrophoresis (PFGE) and multilocus variable-number tandem repeat analysis (MLVA) were employed as comparator typing methods. The virulence gene profiles of isolates from the 2012 and 2014 Alberta outbreak events and contemporary sporadic isolates were mostly identical; therefore the set of virulence genes chosen in the study were not discriminatory enough to distinguish between outbreak clusters. Concordant with PFGE and MLVA results, core genome single-nucleotide variations (SNV) and k-mer phylogenies clustered isolates from the 2012 and 2014 outbreaks as distinct events. The k-mer phylogenies demonstrated increased discriminatory power compared with core SNV phylogenies.

The authors concluded that whole genome sequencing (WGS) holds significant potential to replace current gold-standard typing methods such as PFGE for the routine surveillance and detection of enteric outbreaks. This shift will be driven by the advantages offered by WGS such as increased discriminatory power and genetic resolution. The study was published on November 26, 2015, in the journal Eurosurveillance.

Related Links:

Alberta Provincial Laboratory for Public Health
Fluidigm 
Life Technologies, Inc. 



New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.